Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Harm Reduction Journal|December 3, 2022
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluationAmy Corneli, Brian Perry, Andrea Des Marais, et al.Cell Reports|August 9, 2018
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic ReprogrammingCarl Ward, Giacomo Volpe, Pierre Cauchy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2026
Financial Hardship Before Diagnosis: Influence on Late-Stage Cancer Presentation and the Role of ScreeningSara Khor, Kaiyue Yu, Catherine R Fedorenko, et al.Nature Communications|November 24, 2021
G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediatorsMalarvizhi Gurusamy, Denise Tischner, Jingchen Shao, et al.Harm Reduction Journal|March 27, 2024
Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot studyMehri S McKellar, Andrea C Des Marais, Hillary Chen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2021
Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial PhenotypeLena Hansen, Niklas Lohfink, Rajkumar Vutukuri, et al.The International Journal on Drug Policy|September 19, 2024
A call for compassionate opioid overdose responseErin Russell, Mary Hawk, Joanne Neale, et al.The Journal of Head Trauma Rehabilitation|September 18, 2024
Seizure Risk Associated With the Use of Transcranial Magnetic Stimulation for Coma Recovery in Individuals With Disordered Consciousness After Severe Traumatic Brain InjuryDavid Ripley, Kelly Krese, Joshua M Rosenow, et al.Journal of Medicinal Chemistry|November 24, 2021
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase InhibitorsFelix F Lillich, Sabine Willems, Xiaomin Ni, et al.Annals of Neurology|June 23, 2025
Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System-A Multicenter Cohort Study in 163 PatientsAnna Lena Fisse, Nadine Bonberg, Carolin Beuker, et al.Pageof 8